Trials / Completed
CompletedNCT04961385
Immunogenicity of the ChAdox1 n CoV-19 Vaccine With 12-dose Vial
Immunogenicity of the ChAdox1 n CoV-19 Vaccine Against SARS-CoV-2 With 12-dose Vials: an Interim Analysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Bangkok Metropolitan Administration Medical College and Vajira Hospital · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
ChAd0x1 nCoV-19 (AZD 1222) is the main vaccine that is planned to roll-out in Thailand and involve vaccinating people especially in high-risk categories. This vaccine is contained in the multiple-dose vial for vaccinating 10 recipients for 0.5 mL each. However, the additional volume of vaccine was overfilled to 6.5 mL per vial which the vaccination can be administered to more than 10 doses. The University Hospital Network (UHOSNET) and Faculty of Medicine Vajira Hospital, Navamindradhiraj University have jointly stipulated the preparation and vaccination of ChAdox1 - n CoV-19 vaccine with 12 doses per vial injection with traditional 21 or 24 G needle. Taken together, The investigators planned to investigate the immune response of participants after first dose of ChAd0x1 nCoV-19 vaccination with such technique
Detailed description
The investigators measured anti-SARS-CoV-2 antispike RBD IgG and neutralizing antibody by surrogate virus neutralizing test (sVNT) in adults between age 18-72 year after first dose of ChAd0x1 nCoV-19 vaccine.The primary outcome was the antibody levels.The secondary outcome were adverse events,factors affecting antibody levels and incidence of COVID-19 infection at the time of study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Immunogenicity after first dose of participants who received first dose of ChAdox-1 n COV-19 vaccine | Blood samples were taken from the vaccinated participants for antibody testing against SARS-CoV-2 |
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2021-05-31
- Completion
- 2021-05-31
- First posted
- 2021-07-14
- Last updated
- 2021-07-14
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT04961385. Inclusion in this directory is not an endorsement.